HKSE •
Healthcare •
Drug Manufacturers - Specialty & Generic •
Quote as of 09/10/2026 16:08
Company Profile
IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeHKSE
Market Capitalization6,984.15 mln
Float3,664 mln
Earnings Date04/01/2027
EPS
0.02
Overpriced
P / E
37.00
Overvalued
Piotroski F-Score
7
/ 9
Strong
Beneish M-Score
-2
Caution advised
1-Year Forecast
2.04
Transformational upside
Relative Strength
17
/ 100
Significantly lagging
Business Description
Sihuan Pharmaceutical Holdings Group Ltd. is a Hong Kong-based company founded in 2001 that develops, manufactures, and sells a wide range of medicines and medical aesthetic treatments across China and international markets. Its pharmaceutical portfolio covers conditions affecting the heart, brain, lungs, digestive system, and other major areas of health, while its aesthetics business offers body contouring, skin care, and minimally invasive cosmetic procedures. The company also runs general hospital services, making it an active participant across several areas of healthcare.
